Clinical outcomes after percutaneous coronary intervention for early versus late and very late stent thrombosis: a systematic review and meta-analysis

被引:0
作者
Yi-Xing Yang
Yin Liu
Xiao-Wei Li
Peng-Ju Lu
Jiao Wang
Chang-Ping Li
Jing Gao
机构
[1] Tianjin Medical University,Department of Cardiology
[2] Tianjin Chest Hospital,undefined
[3] Cardiovascular Institute,undefined
[4] Tianjin Chest Hospital,undefined
来源
Journal of Thrombosis and Thrombolysis | 2021年 / 51卷
关键词
Stent thrombosis; Outcomes; Percutaneous coronary intervention; Meta-analysis;
D O I
暂无
中图分类号
学科分类号
摘要
Whether the clinical outcomes of stent thrombosis (ST) are different when stratified by time of occurrence remains unclear. The objective of this study was to compare the short- and long-term clinical outcomes after percutaneous coronary intervention (PCI) for early stent thrombosis (EST) versus late stent thrombosis (LST) and very late stent thrombosis (VLST). We enrolled eligible studies searched from the main electronic databases (EMBASE, PubMed, Cochrane). The primary endpoints were in-hospital, 30-day, 1-year and long-term mortality. The secondary endpoints included recurrent stent thrombosis (RST) and target vessel/lesion revascularization (TVR/TLR) during hospitalization, at 30 days, at 1 year and at long-term follow-up. A total of 23 studies with 17,592 patients were included. Compared with mortality rates of the late and very late thrombosis (LST/VLST) group, in-hospital (P = 0.004), 30-day (P < 0.00001), 1-year (P < 0.00001) and long-term mortality rates (P = 0.04) were significantly higher in the EST group. The in-hospital TVR/TLR rates were similar between the EST group and the LST/VLST group. However, a higher trend in TVR/TLR rate at 30 days and a significantly higher TVR/TLR rate at 1 year (P = 0.002) as well as at long-term follow up (P = 0.009) were found in the EST group. EST patients also trended toward higher risk of RST in both short- and long-term follow-up than LST/VLST patients, although differences were not statistically significant. After PCI treatment, patients with EST have worse clinical outcomes in both short- and long-term follow-up than patients with LST/VLST. Further studies are warranted to determine the optimal treatment strategies for EST.
引用
收藏
页码:682 / 692
页数:10
相关论文
共 122 条
[1]  
Iqbal J(2013)Incidence and predictors of stent thrombosis: a single-centre study of 5,833 consecutive patients undergoing coronary artery stenting EuroIntervention 9 62-69
[2]  
Sumaya W(2019)Incidence, angiographic and clinical predictors, and impact of stent thrombosis: a 6-year survey of 6,545 consecutive patients Neth Heart J 27 321-329
[3]  
Tatman V(2007)Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2344-2351
[4]  
Rozemeijer R(2009)Clinical manifestation and prognosis of early versus late stent thrombosis of drug-eluting stents J Interv Cardiol 22 228-233
[5]  
Wing WC(2016)Prevalence and outcomes of early versus late stent thrombosis presenting as ST-segment elevation myocardial infarction Coron Artery Dis 27 667-672
[6]  
Leenders G(2013)Contemporary analysis of incidence and outcomes of stent thrombosis presenting as ST elevation myocardial infarction in a primary percutaneous coronary intervention cohort Am J Cardiol 112 1347-1354
[7]  
Cutlip DE(2010)Comparisons of baseline demographics, clinical presentation, and long-term outcome among patients with early, late, and very late stent thrombosis of sirolimus-eluting stents: Observations from the Registry of Stent Thrombosis for Review and Reevaluation (RESTART) Circulation 122 52-61
[8]  
Windecker S(2014)Comparison of long-term outcome after percutaneous coronary intervention for stent thrombosis between early, late, and very late stent thrombosis Circ J 78 101-109
[9]  
Mehran R(2012)Clinical presentation, management, and outcomes of angiographically documented early, late, and very late stent thrombosis JACC Cardiovasc Interv 5 131-140
[10]  
Lemesle G(2008)Drug-eluting stent thrombosis: results from the multicenter Spanish registry ESTROFA (Estudio ESpañol sobre TROmbosis de stents FArmacoactivos) J Am Coll Cardiol 51 986-990